This two-day event will bring together leaders from academia, industry, healthcare, regulatory agencies, and policymaking to explore the key opportunities, challenges, and innovations shaping the future of biotechnology. Through insightful presentations and dynamic discussions, attendees will engage with experts at the forefront of the sector.
Featuring Speakers:
- Prof. Susa Benseler, Chief Academic Officer, Children’s Health Ireland
- Prof. Lydia Lynch, Professor of Molecular Biology, Princeton University
- Dr. Claire Skentelbery, Director General of EuropaBio
- Prof. John Morrissey, Lead of IBISBA-IE, University College Cork
- Dr. Brendan Hughes, former SVP Global Manufacturing at BMS
- Prof. Aedín Culhane, Professor of Cancer Genomics, University of Limerick
- Prof. Qasim Rafiq, Professor of Bioprocess Engineering, University College London
- Assoc. Prof. Jonathan Bones, Director of CONCEPT
- Assoc. Prof. Colin Clarke, NIBRT Principal Investigator
- Panel Discussion – Moderated by Dr. Barry Heavey
Thanks to our sponsors
Research at NIBRT
NIBRT Research is a world leader in developing innovative technologies that advance biopharmaceutical manufacturing and a resource for the global biopharmaceutical industry. Inspired by the manufacturing challenges facing the industry, NIBRT Research makes transformative discoveries across multidisciplinary areas such as analytical science, cell and genetic engineering, informatics, and bioprocess engineering. These discoveries are utilised to advance the state-of-the-art in their fields and revolutionise the manufacturing of recombinant proteins, vaccines and cell and gene therapies.
NIBRT's recent large scale expansion to our existing facility includes five new laboratories dedicated to research in advanced therapies. This expansion will increase NIBRT’s capability in Advanced Therapy Medicinal Products (ATMPs) including Cell and Gene Therapy (CGT) research and training. The €21 million project is funded by the IDA Ireland and the Government of Ireland and will become an integral part in placing Ireland at the forefront of ATMP research, training and innovation.
About NIBRT
NIBRT supports the growth and advancement of the biopharma manufacturing industry by offering state-of-the-art training and research solutions. Through a unique collaboration between industry, government, and academia, NIBRT opened its world-class facility in Dublin, Ireland in 2011.
The facility was primarily funded by IDA Ireland (Industrial Development Agency), Ireland's inward investment promotion agency, which is dedicated to attracting and developing foreign investment in Ireland. As a result, NIBRT provides an unparalleled training and research experience that was previously unavailable anywhere in the world
